India to Sudan: Ceftazidime Export Trade Route

The India to Sudan Ceftazidime corridor is one of India's established pharmaceutical export routes, with 38 shipments documented worth a combined $850.9K USD. The route is dominated by SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI, which alone accounts for roughly 20% of all export value, reflecting the consolidated nature of India's ceftazidime manufacturing sector.

Across 14 active suppliers, the average shipment value stands at $22.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with ceftazidime's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 22.8%, placing it at rank #11 among India's top ceftazidime export destinations globally.

On the import side, key buyers of Indian ceftazidime in Sudan include TO THE ORDER OF, TO THE DIRECTOR OF, M S AMIPHARMA LABORATORIES LIMITED and 11 others. TO THE ORDER OF is the single largest importer with 7 shipments valued at $307.6K USD.

India's ceftazidime exports to Sudan are driven primarily by a handful of large-scale manufacturers. SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI with 9 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 14 active exporters signals a competitive but concentrated market — buyers in Sudan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI, INJECT CARE PARENTERALS PRIVATE LIMITED, KILITCH DRUGS INDIA LIMITED — together account for 57% of total trade value on this route. The average shipment value of $22.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as ceftazidime for injection usp 1 gm and sterile water for injection usp injidime 1 gm batch no.i251023001/i2510230 and injection amizidime 1g ceftazidime for injection usp 1g batch no mmic23001 to mmic23004 manufacturing date aug 2023/ exp date, suggesting that buyers in Sudan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF is the largest importer with 7 shipments worth $307.6K USD — representing 36% of all ceftazidime imports from India on this route. A total of 14 buyers are active on this corridor.